Background: Hemophagocytic syndrome (HPCS) is not rare in Thailand. At present the outcome in severe cases is often unsatisfactory because of a delay in diagnosis and improper management. From 1999 to 2011, the authors have gained experience in the management of severe acquired nonmalignant HPCS in Thai adult patients. From 1999 to 2003, three out of 10 patients died. During 2005-2011, seven patients with severe HPCS survived. This improvement stimulated the authors to analyze clinical manifestations, etiology, and management of these patients.
Objective: To find the keys to successful outcomes in the management of acquired severe nonmalignant HPCS in seven survivors during 2005-2011. To alert physicians that acquired severe nonmalignant HPCS may be cured.
Materials and Methods: The records of ten patients with HPCS were analyzed. Between 1999 and 2003 three patients died. Between 2005 and 2011 seven patients survived.
Results: The three patients during 1991-2003 may well have died because of delayed diagnosis and improper management. One case of HPCS was diagnosed after death. In the other two cases etiologies were not readily identified and dealt with. In the surviving group, treatment was started as soon as HPCS was suspected or diagnosed. This consisted of removal of any known cause and aggressive management of associated conditions and complications.
Conclusion: Adults who acquire severe nonmalignant HPCS can be treated successfully. The key roles for this success are early diagnosis and appropriate management. The best supportive care and close observation by the team of hematologists and physicians also determines patient survival.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. Chandra P Chaudhery SA Rosner F Kagen M. Transient histiocytosis with striking phagocytosis of platelets leukocytes and erythrocytes. Arch Intern Med. 1975; 135:989-91.
2. Srichaikul T Punygupta S Mongkolsritrakul W Jidpugdeebodin S. Hemophagocytic syndrome: an analysis of seven cases and review of the literature. Intern Med J Thai. 2004; 20:258-270.
3. Emmenegger U Frey U Reimers A Fux C Semela D Cottagnoud P et al. Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. American J Hematol. 2001; 68:4-10.
4. Okamoto M Yamaguchi H Isobe Y Yokose N Mizuki T Tajika K et al. Analysis of triglyceride value in the diagnosis and treatment response of secondary hemophagocytic syndrome. Inter Med. 2009; 48: 775-81.
5. Wong KF Chan JK. Reactive hemophagocytic syndrome-a clinicopathologic study of 40 patients in an oriental population. American J Med. 1992; 93: 177-80.
6. Shiraishi K Tanaka K Okubo Y Sakamoto A Jojima H Fukahori S et al. Clinical study of infection associated hemophagocytic syndrome. Kansenshogaku Zasshi. 2000; 74:630-7.
7. Reiner A Spivak J. Hematophagic histiocytosis. Medicine. 1988; 67:369-88.
8. Risdall RJ McKenna RW Nesbit ME Krivit W Balfour HH Jr Simmons RL Brunning RD. Virusassociated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer. 1979; 44:993-1002.
9. Sullivan JL Woda BA Herrod HG Koh G Rivara FP Mulder C. Epstein-Barr virus-associated hemophagocytic syndrome: virological and immunopathological studies. Blood. 1985; 65:1097-104.
10. Wong KF Chan JKC Lo ESF Wong CSC. A study of the possible etiologic association of Epstein-Barr Virus with reactive hemophagocytic syndrome in Hong Kong Chinese. Human Pathology. 1996; 27: 1239-42.
11. Okano M Gross TG. Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis. Am J Hematol. 1996; 53:111-5.
12. Imashuku S Miyagawa A Chiyonobu T Ishida H Yoshihara T Kuriyama K et al. EBV associated T lymphoproliferative disease with hemophagocytic syndrome followed by fatal intestinal B lymphoma in a hypogammaglobulinemia infectious and myelokathexis. Ann Hematol. 2002; 81:470-3.
13. Mitarnum W Saechan V Pradutkanchana J Suwiwat Takao S Ishida T. EBV associated peripheral T cell lymphoma with gastrointestinal tract involvement. J Med Assoc Thai. 2003; 86:816-28.
14. Srichaikul T Punyagupta S Mongkolsritrakul W Jidpugdeebodin S. EBV and hemophagocytic syndrome: analysis of 3 cases with speculation on clinical features therapy and role of EBV. J Med Assoc Thai. 2004; 87:974-83.
15. Srichaikul T Punyagupta S Kanchanapoom T Chanokovat C Likittanasombat K Leelasiri A. Hemophagocytic syndrome in dengue hemorrhagic fever with severe multiorgan complications. J Med Assoc Thai. 2008; 91:104-9.
16. Sorakhunpipitkul L Punyagupta S Srichaikul T Tribuddharat S. Thai adult dengue hemorrhagic fever during 2008-2010: seven cases presented with severe multiorgan failure and successfully treated with high dose of corticosteroids and intravenous immunoglobulin G. J Infect Dis Antimicrob Agents. 2011; 28: 99-103.
17. Srichaikul T Punygupta S Mongkolsritrakul W Jidpugdeebodin S. Hemophagocytic syndrome: an analysis of 7 cases and the literatures review. Thai J of Hematol and Transfusion Med. 2004: 14:263-80.
18. Mootsikapun P Sirijerachai C Chansung K Nanagara R. Acute lupus hemophagocytic syndrome: report of a case and review of the literature. J Med Assoc Thai. 2004; 87:333-9.
19. Kawashima M Yamamura M Taniai M Yamauchi H Tanimoto T Kurimoto M et al. Levels of IL18 and its binding inhibitors in the blood circulation of patients with adult-onset still disease. Arthritis Rheuma. 2001; 44:550-60.
20. Srichaikul T Punyagupta S Mongkolsritrakul W Peutpol S Leechawengwongs M Chanokovat C. Hemophagocytic syndrome with fulminant multi-organ failure after tasting raw monkfish liver: the patient survived by immunomodulators and plasma exchange therapy. J Hematol Transfus Med. 2011; 21:261-6.
21. Srichaikul T Mongkolsritrakul W. Hemophagocytic Syndrome in Textbook of Hematology-Diagnosis and Treatment of Common Blood Disease in Thailand. Ed. Prayoonwiwat P. Juta S. Srichaikul T. Numuksorn. 2007 3rd edition. Chapter 34 p.599-619.
22. Szyper-Kravitz M. The hemophagocytic syndrome/ macrophage activation syndrome: a final common pathway of a cytokine storm. Israel Med Assoc J. 2009; 11:633-4.
23. Tang YM Xu XJ. Advances in hemophagocytic lymphohistiocytosis: pathogenesis early diagnosis/ differential diagnosis and treatment. The Scientific World J. 2011; 11:697-708.
24. Larroche C Mouthon L Larroche L Mouthon C. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmunity Reviews. 2004; 3:69-75.
25. Filipovich AH. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Am Soc Hematol. 2009: 127-31.
26. Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol. 2002; 44:259-72.
27. Iso-O N Hashimoto N Tanaka A Sunaga S Oka T Kurokawa K et al. Cytokine-induced hypoalbuminemia in a patient with hemophagocytic syndrome direct in vitro evidence for the role of tumor necrosis factor-a. Digest Dis Sci. 1998; 43:67-73.
28. Emmenegger U Schaer DJ Larroche C Neftel KA. Haemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wkly. 2005; 135:299-314.
29. Omagari K Ashida R Oh-I H Minamino Y Sasaki O Ozono Y et al. Successful treatment with cyclosporine in a case of hemophagocytic syndrome manifesting as severe liver dysfunction. Am J Med. 1997; 314:403-7.
30. Erduran E Gedik Y Sen Y Yildiran A. Successful treatment of reactive hemophagocytic syndrome with cyclosporin A and intravenous immunoglobulin. Turk J Pediatr. 2000; 42:168-70.
31. Estlin EJ Palmer RD Windebank KP Lowry MF Pearson ADJ. Successful treatment of non-familial haemophagocytic lymphohistiocytosis with interferon and gammaglobulin. Arch Dis Child. 1996; 75:432-5.
32. Tsuda H Shirono K. Successful treatment of virusassociated haemophagocytic syndrome in adults by cyclosporin A supported by granulocyte colonystimulating factor. British J Haematol. 1996; 93:572-5.
33. Matsumoto Y Naniwa D Banno S Sugiura Y. The efficacy of therapeutic plasmapheresis for the treatment of fatal hemophagocytic syndrome: two case reports. Therapeutic Apheresis. 1998; 2: 300-4.
34. Satomi A Nagai S Nagai T Niikura K Ideura T Ogata H Akizawa T. Effect of plasma exchange on refractory hemophagocytic syndrome complicated with myelodysplastic syndrome. Ther Apher. 1999; 3: 317-9.
35. Jaing TH Chiu CH Lo WC Lu CS Chang KW. Epstein-Barr virus-associated hemophagocytic syndrome masquerading as lymphoma: a case report. J Microbiol Immunol Infect. 2001; 34:147-9.
36. Sorakhunpipitkul L Srichaikul T Thanakitcharu S Kengsakul K Punyarit P. Epstein Barr Virus (EBV) associated hemophagocytic syndrome (HPC) causing respiratory failure and massive lymphadenopathy: successfully treated with intravenous acyclovir pulse methylprednisolone and intravenous immunoglobulin G-report of One case and review literatures. Journal of Hematology and Transfusion Medicine. 2011; 21: 95-101.
37. Kikuta H Skiyama Y Matsumoto S Oh-Ishi T Nakano T Nagashima T et al. Fatal Epstein-Barr virus-associated hemophagocytic syndrome. Blood. 1993; 82:3259-64.
39. Strecker A Bernardi F Hendricx S Detourmignies L. Fatal hemophagocytic syndrome following infectious mononucleosis in a non-immunosuppressed subject. Press Med. 1995; 24:651.
40. Albrecht H Schafer H Stellbrink HJ Greten H. Epstein-Barr virus-associated hemophagocytic syndrome a cause of fever of unknown origin in human immunodeficiency virus infection. Arch Pathol Lab Med. 1997; 121:853-8.
41. Mihara H Kato Y Tokura Y Hattori Y Sato A Kobayashi H et al. Epstein-Barr virus-associated hemophagocytic syndrome during mid-term pregnancy successfully treated with combined methylprednisolone and intravenous immunoglobulin. Rinsho Ketsueki. 1999; 40:1258-64.
42. Al-Talag AH Mohamed AE Dafulla MM Ghandour Z Al-Karawi MA Haleem A. Hemophagocytic syndrome. Saudi Med J. 2000; 21:979-82.
43. McManus TE Coyle PV Lawson J Elborn JS Kidey J. Epstein-Barr virus pneumonitis. Ulster Med Soc. 2009; 78:137-8.